Analgesia in Minimally Invasive Direct Coronary Artery Bypass Grafting: Programmed Intermittent Bolus Infusions of Erector Spinae Plane Block Versus Paravertebral Block
Comparison of Programmed Intermittent Bolus Infusions of Spinae Plane Block Versus Paravertebral Block for Analgesia in Minimally Invasive Direct Coronary Artery Bypass Grafting
1 other identifier
interventional
140
1 country
2
Brief Summary
Paravertebral block (PVB) has been regarded as effective regimen for pain control after cardiac surgery. As a novel analgesia technique, erector spinae plane block (ESPB) has been reported to provide effective analgesia after thoracic and cardiac surgery. We hypothesized that the ESPB is non-inferior to PVB in treating pain in minimally invasive direct coronary artery bypass surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2022
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 21, 2022
CompletedFirst Posted
Study publicly available on registry
April 11, 2022
CompletedStudy Start
First participant enrolled
April 15, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2023
CompletedApril 23, 2026
January 1, 2025
1 year
March 21, 2022
April 20, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
pain at cough after surgery
Numerical Rating Pain Scale, where 0=No Pain (better outcome) and 10=Intractable Pain (worse outcome)
postoperatively 0-3 day
postoperative rescue analgesic consumption
morphine equivalents
postoperatively 0-3 day
Secondary Outcomes (3)
pain at rest after surgery
postoperatively 0-3 day
adverse events of regional block
Intraoperative (during and immediately after block performance)
dermatome of block
immediately after extubation
Other Outcomes (10)
pulmonary function
preoperative and postoperative day 1 and 3
postoperative complications: cardiac, pulmonary, cerebral, opioid intake
3 days postoperatively
recovery time
postoperatively, up to 4 weeks
- +7 more other outcomes
Study Arms (2)
erector spinae plane block
EXPERIMENTALA needle is inserted until the tip contacted the T5 transverse process under ultrasound guidance. After confirming the needle tip position, 20 ml of 0.5% ropivacaine was injected in the plane between the erector spinae muscles and transverse process. A catheter is inserted through the needle and then connected to a Programmed Electronic Postoperative Analgesia Pump with a programmed intermittent bolus of 10 ml ropivacaine 0.2% every 2 h after surgery
thoracic paravertebral block
ACTIVE COMPARATORA needle is inserted into the paravertebral space. After confirming the needle tip position, 20 ml of 0.5% ropivacaine is injected in the paravertebral space. A catheter is inserted through the needle and then connected to a Programmed Electronic Postoperative Analgesia Pump with a programmed intermittent bolus of 10 ml ropivacaine 0.2% every 2 h after surgery.
Interventions
20 ml of 0.5% ropivacaine as bolus and a programmed intermittent bolus of 10 ml ropivacaine 0.2% every 2 h after surgery
Eligibility Criteria
You may qualify if:
- patients undergoing elective minimally invasive direct coronary artery bypass grafting
You may not qualify if:
- Contraindications to regional anesthesia (coagulopathy, infection of the skin at the site of needle puncture area, et al)
- Morbid obesity (body mass index \> 35 kg/m2)
- Allergy to any of the study drugs
- Chronic opioid use or history of opioid abuse.
- Inability to understand pain score
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Department of Anesthesiology,Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
Peking University Third Hosptial
Beijing, 100191, China
Related Publications (3)
Gurkan Y, Aksu C, Kus A, Yorukoglu UH. Erector spinae plane block and thoracic paravertebral block for breast surgery compared to IV-morphine: A randomized controlled trial. J Clin Anesth. 2020 Feb;59:84-88. doi: 10.1016/j.jclinane.2019.06.036. Epub 2019 Jul 4.
PMID: 31280100BACKGROUNDSaadawi M, Layera S, Aliste J, Bravo D, Leurcharusmee P, Tran Q. Erector spinae plane block: A narrative review with systematic analysis of the evidence pertaining to clinical indications and alternative truncal blocks. J Clin Anesth. 2021 Feb;68:110063. doi: 10.1016/j.jclinane.2020.110063. Epub 2020 Oct 5.
PMID: 33032124BACKGROUNDHuang W, Wang W, Xie W, Chen Z, Liu Y. Erector spinae plane block for postoperative analgesia in breast and thoracic surgery: A systematic review and meta-analysis. J Clin Anesth. 2020 Nov;66:109900. doi: 10.1016/j.jclinane.2020.109900. Epub 2020 Jun 2.
PMID: 32502778BACKGROUND
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Min Li, MD
Peking University Third Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Vice Director of the Department of Anesthesiology, Principal Investigator, Clinical Professor
Study Record Dates
First Submitted
March 21, 2022
First Posted
April 11, 2022
Study Start
April 15, 2022
Primary Completion
April 30, 2023
Study Completion
December 30, 2023
Last Updated
April 23, 2026
Record last verified: 2025-01